dr. ferris on a trial testing adu-s100/miw815/pembrolizumab in head and neck cancer
Published 4 years ago • 182 plays • Length 0:54Download video MP4
Download video MP3
Similar videos
-
0:53
dr. ferris on combining sting agonists with checkpoint inhibitors in head and neck cancer
-
1:34
dr. ferris discusses nivolumab in head and neck cancer
-
1:09
dr. ferris on ongoing research with sting agonists/checkpoint inhibitors in head and neck cancer
-
0:58
dr. machiels on pembrolizumab in head and neck cancer
-
1:05
rationale for evaluating sting agonists in head and neck cancer
-
1:03
dr. zandberg on durvalumab trial in head and neck cancer
-
1:59
pembrolizumab in the treatment of head and neck cancer: is there more to the story?
-
1:16
dr. ferris on the safety profile of transoral robotic surgical resection in oropharynx cancer
-
6:35
pembrolizumab as first-line therapy for recurrent/metastatic head and neck cancer
-
10:09
diagnosis, staging, and prognosis
-
1:27
where to go next with pembrolizumab and other anti-pd-1 therapies in head and neck cancer
-
6:10
pd-1 inhibitor pembrolizumab shows promising clinical activity for triple-negative breast cancer
-
15:12
part 8 - immunotherapy and targeted therapy update in head and neck cancer - dr ankur bhal, - delhi
-
1:37
dr. cohen on the value of pfs as an endpoint in head and neck cancer
-
6:37
caspian trial: durvalumab and chemotherapy in es-sclc
-
10:28
multiple endocrine neoplasia: a typical case with atypical pathology - alex schray
-
1:04:13
pfo closure with amplatzer™ talisman™ pfo occluder: outcomes in patients 60 years
-
0:56
psa ⎯ to test or not to test? (media version with download links)
-
1:34
dr. pino aliperti and dr. adam elfant on the innovation of the ascope™ duodeno